Rac GTPases in hematological malignancies

19Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies.

Cite

CITATION STYLE

APA

Durand-Onaylı, V., Haslauer, T., Härzschel, A., & Hartmann, T. N. (2018, December 14). Rac GTPases in hematological malignancies. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms19124041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free